Asthma May Not Boost Odds Of Severe Covid-19 ⭐

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

: Daily maintenance with inhaled corticosteroids (ICS) —the standard treatment for asthma—may reduce the body's inflammatory response to the virus, potentially preventing the "cytokine storms" that lead to severe illness. A Note of Caution: Control is Key

: The SARS-CoV-2 virus enters cells via a receptor called ACE2 . In many people with allergic asthma, the expression of this receptor is naturally lower, giving the virus fewer "doors" to enter through. Asthma May Not Boost Odds of Severe COVID-19

However, as years of data have poured in, a surprising and reassuring story has emerged. Recent studies, including a major scoping review published in , indicate that asthma is not an independent risk factor for severe COVID-19 illness. The Protective Paradox

For most, the message is clear: staying consistent with daily medications and keeping asthma well-controlled provides a robust layer of protection, allowing many to "breathe easier" despite the ongoing presence of the virus. This is for informational purposes only

: People with asthma often have higher counts of eosinophils , a type of white blood cell. Research suggests these cells may help degrade viral RNA and boost the immune defense specifically against this virus.

The story isn't the same for everyone. While asthma in general may not boost the odds of severe outcomes, remains a concern. A large-scale Swedish study published in February 2026 found that patients with very poor symptom control or frequent flare-ups still faced a higher risk of hospitalization if they contracted the virus. Learn more : Daily maintenance with inhaled corticosteroids

Scientists have discovered several biological reasons why asthma might actually offer a strange kind of protection: